These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


272 related items for PubMed ID: 12225705

  • 21. Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial.
    Rennard SI, Glover ED, Leischow S, Daughton DM, Glover PN, Muramoto M, Franzon M, Danielsson T, Landfeldt B, Westin A.
    Nicotine Tob Res; 2006 Aug; 8(4):555-64. PubMed ID: 16920653
    [Abstract] [Full Text] [Related]

  • 22. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking.
    Benowitz NL, Zevin S, Jacob P.
    Br J Clin Pharmacol; 1997 Mar; 43(3):259-67. PubMed ID: 9088580
    [Abstract] [Full Text] [Related]

  • 23. A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms.
    George TP, Termine A, Sacco KA, Allen TM, Reutenauer E, Vessicchio JC, Duncan EJ.
    Schizophr Res; 2006 Oct; 87(1-3):307-15. PubMed ID: 16854565
    [Abstract] [Full Text] [Related]

  • 24. The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia.
    Chou KR, Chen R, Lee JF, Ku CH, Lu RB.
    Int J Nurs Stud; 2004 Mar; 41(3):321-30. PubMed ID: 14967189
    [Abstract] [Full Text] [Related]

  • 25. The nicotinergic receptor as a target for cognitive enhancement in schizophrenia: barking up the wrong tree?
    Quisenaerts C, Morrens M, Hulstijn W, de Bruijn E, Timmers M, Streffer J, De la Asuncion J, Dumont G, Sabbe B.
    Psychopharmacology (Berl); 2014 Feb; 231(3):543-50. PubMed ID: 24022237
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study.
    Hjalmarson A, Franzon M, Westin A, Wiklund O.
    Arch Intern Med; 1994 Nov 28; 154(22):2567-72. PubMed ID: 7979853
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Electronic monitoring of long-term use of the nicotine nasal spray and predictors of success in a smoking cessation program.
    Schneider MP, van Melle G, Uldry C, Huynh-Ba M, Fallab Stubi CL, Iorillo D, Burnier M, Zellweger JP.
    Nicotine Tob Res; 2003 Oct 28; 5(5):719-27. PubMed ID: 14577988
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Dose-related cardiovascular and endocrine effects of transdermal nicotine.
    Zevin S, Jacob P, Benowitz NL.
    Clin Pharmacol Ther; 1998 Jul 28; 64(1):87-95. PubMed ID: 9695723
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo-controlled trial.
    Stapleton JA, Sutherland G.
    Addiction; 2011 Apr 28; 106(4):824-32. PubMed ID: 21205043
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Smokers' expectancies for nicotine replacement therapy vs. cigarettes.
    Juliano LM, Brandon TH.
    Nicotine Tob Res; 2004 Jun 28; 6(3):569-74. PubMed ID: 15203790
    [Abstract] [Full Text] [Related]

  • 40. Carcinogen exposure during short-term switching from regular to "light" cigarettes.
    Benowitz NL, Jacob P, Bernert JT, Wilson M, Wang L, Allen F, Dempsey D.
    Cancer Epidemiol Biomarkers Prev; 2005 Jun 28; 14(6):1376-83. PubMed ID: 15941944
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.